208 related articles for article (PubMed ID: 10771610)
1. [Effects of human papilloma virus types on course of juvenile respiratory papillomatosis and effectiveness of interferon therapy in children].
Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Brodskiĭ MIu
Vestn Otorinolaringol; 2000; (2):37-40. PubMed ID: 10771610
[TBL] [Abstract][Full Text] [Related]
2. Virological and immunological aspects in the juvenile laryngeal papillomatosis.
Gheorghe DC; Ardelean C; Anton G
Rom J Virol; 1999; 50(1-4):85-9. PubMed ID: 11601383
[TBL] [Abstract][Full Text] [Related]
3. Current advances in the basic research and clinical management of juvenile-onset recurrent respiratory papillomatosis.
Bergler WF; Götte K
Eur Arch Otorhinolaryngol; 2000; 257(5):263-9. PubMed ID: 10923940
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of human papilloma virus types and their influence on the course of the disease in children suffering from recurrent respiratory papillomatosis].
Obchinnikov IuM; Kiselev VI; Soldatskiĭ IuL; Artem'ev MI; Onufrieva EK; Baranovskiĭ PM; Shchepin NV; Smetanina SE; Gasparian SF; Steklov AM
Vestn Otorinolaringol; 2004; (3):29-33. PubMed ID: 15159735
[TBL] [Abstract][Full Text] [Related]
5. Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm.
Doyle DJ; Henderson LA; LeJeune FE; Miller RH
Arch Otolaryngol Head Neck Surg; 1994 Nov; 120(11):1273-6. PubMed ID: 7917213
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease.
Rabah R; Lancaster WD; Thomas R; Gregoire L
Pediatr Dev Pathol; 2001; 4(1):68-72. PubMed ID: 11200493
[TBL] [Abstract][Full Text] [Related]
7. [Virologic aspects of juvenile laryngeal papillomatosis].
Major T; Jókay I; Soós G; Gergely L; Czeglédy J
Orv Hetil; 1999 Feb; 140(8):405-9. PubMed ID: 10083813
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of recurrent respiratory papillomatosis: an expert opinion.
Gallagher TQ; Derkay CS
Expert Opin Pharmacother; 2009 Mar; 10(4):645-55. PubMed ID: 19284366
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and molecular biology studies of respiratory papillomatosis].
Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffmann M; Rudert HH
Laryngorhinootologie; 1998 Mar; 77(3):157-64. PubMed ID: 9577823
[TBL] [Abstract][Full Text] [Related]
10. E6 and E7 oncogene expression by human papilloma virus (HPV) and the aggressive behavior of recurrent laryngeal papillomatosis (RLP).
Shehata BM; Otto KJ; Sobol SE; Stockwell CA; Foulks C; Lancaster W; Gregoire L; Hill CE
Pediatr Dev Pathol; 2008; 11(2):118-21. PubMed ID: 17990904
[TBL] [Abstract][Full Text] [Related]
11. Assessment of human papilloma virus infection in adult laryngeal papilloma using a screening test.
Makiyama K; Hirai R; Matsuzaki H; Ikeda M
J Voice; 2013 Mar; 27(2):230-5. PubMed ID: 23273988
[TBL] [Abstract][Full Text] [Related]
12. HPV types causing juvenile recurrent laryngeal papillomatosis in South Africa.
Seedat RY; Thukane M; Jansen AC; Rossouw I; Goedhals D; Burt FJ
Int J Pediatr Otorhinolaryngol; 2010 Mar; 74(3):255-9. PubMed ID: 20018386
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and molecular biology studies of laryngeal papillomatosis].
Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffman H; Rudert HH
Laryngorhinootologie; 1998 Jan; 77(1):27-33. PubMed ID: 9522309
[TBL] [Abstract][Full Text] [Related]
14. Juvenile-onset recurrent respiratory papillomatosis involving the lung: A case report and review of the literature.
Magid MS; Chen YT; Soslow RA; Boulad F; Kernan NA; Szabolcs P
Pediatr Dev Pathol; 1998; 1(2):157-63. PubMed ID: 9507042
[No Abstract] [Full Text] [Related]
15. Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up.
Gerein V; Rastorguev E; Gerein J; Jecker P; Pfister H
Ann Otol Rhinol Laryngol; 2005 Jun; 114(6):463-71. PubMed ID: 16042104
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis.
Gabbott M; Cossart YE; Kan A; Konopka M; Chan R; Rose BR
J Clin Microbiol; 1997 Dec; 35(12):3098-103. PubMed ID: 9399501
[TBL] [Abstract][Full Text] [Related]
17. Persistence of human papillomavirus type 6e in adult multiple laryngeal papilloma and the counterpart false cord of an interferon-treated patient.
Ogura H; Watanabe S; Fukushima K; Baba Y; Masuda Y; Fujiwara T; Yabe Y
Jpn J Clin Oncol; 1993 Apr; 23(2):130-3. PubMed ID: 8390585
[TBL] [Abstract][Full Text] [Related]
18. 2',5'-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis.
Gerein V; Rastorguev E; Gerein J; Lodemann E; Pfister H; Draf W; Desloovere C
J Laryngol Otol; 2004 Oct; 118(10):750-6. PubMed ID: 15550179
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of resistance to interferon in patients with laryngeal papillomatosis.
Garciá-Millián R; Santos A; Perea SE; González-Cabañas R; Valenzuela C; Araña M
Cytokines Cell Mol Ther; 1999 Jun; 5(2):79-85. PubMed ID: 10515680
[TBL] [Abstract][Full Text] [Related]
20. Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma.
Lele SM; Pou AM; Ventura K; Gatalica Z; Payne D
Arch Pathol Lab Med; 2002 Oct; 126(10):1184-8. PubMed ID: 12296755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
